Illumina Inc. (NASDAQ: ILMN) is a large market cap stock with a market cap of 21798.33. It is in the Biotechnology industry and sector Healthcare, with a current P/E of 53.78, a forward P/E of 37.58 and EPS of 2.78. At a stock price of 148.7 (-0.58%) it has a dividend yield of *TBA.
EPS growth for the last five years have been 28.90%, more recently this last year it has grown by 30.50%. The next year growth is going to be about 18.00% and more long-term 16.58% after five years. EPS growth quarter over quarter is -34.30%. Sales growth for the past five years have been 19.70% and sales growth quarter over quarter is 6.20%.
For performance, Illumina Inc. the past week has seen a gain of 7.11%. For the last month performance for Illumina Inc. is 9.70%. While the last quarter is -16.03% and half year, -12.61%. Finally for the year, performance is -37.62%.
The 52-week high for Illumina Inc., is at -38.65%, and for the 52-week low it comes to a value of 16.99%. The 20-day simple moving average is 5.03% and -4.47% for the 200-day simple moving average.
Volatility for the week is at 2.79%, and for the month it is 2.92%. Illumina Inc., has a target price of 153.9.
In terms of debt, long term debt/equity is 0.51, and for total debt/equity Illumina Inc. has 0.51. The gross margin is 69.70%, while operating margin is 24.80%, the profit margin is 18.40%. The current ratio is 4.3 and the quick ratio is 3.7.
Insider ownership is at 1.20%, with instituitional ownership at 96.60%. Illumina Inc. has a payout ratio of 0.00%. With the total shares outstanding coming to 145.74. The shares float is 145.7, with the float short at 5.16%, with short ratio coming to 5.22.
In terms of returns, the return on assets see Illumina Inc., get 11.10%, with its returns on investment at 16.60%. Return on equity is 21.90%. So will the investors see the target price of 153.9, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.